ArticleJournal of medicinal chemistry2021

Discovery of M-1121 as an Orally Active Covalent Inhibitor of Menin-MLL Interaction Capable of Achieving Complete and Long-Lasting Tumor Regression.

Meng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.